United States · Biotechnology startup
United States · Nora Therapeutics
Nora develops therapeutics to address unmet clinical needs in reproductive medicine.
Funding reportedLast round: Series B
Follow Nora Therapeutics and see its new rounds in your feed.Start following
What company datasets say Nora Therapeutics raised
Funding, as reported
Founders and team
From the SEC filings it signed: 1 on the team.
- Jeffrey K. TongExecutive Officer, Directori
On the board, as filediAnupam K. DalalChen K. YuDavid K. SchnellDennis K. FentonDonald K. HaydenJoseph L. TurnerMartin K. Vogelbaum
The company, in detail
What they build
Known for
librariesdigital healthmobile appsclean energy & technologyconsumerscustomer engagementonline casinoenterprisessocial media marketinginternet of thingssports technologysoftware engineeringinformation technology & servicesbig datafinancial servicesai in business
Built with from their website
WordPress.orgFont AwesomeCloudFlareViewport MetaCloudFlare CDNPriority HintsGoogle Font APICloudflare InsightsMySQLPrimeNG
+8 more
Mobile FriendlyOpen GraphjQueryRSSTypeScriptCloudflare DNSYoastHTTP/3
- Sector
- Biotechnology
- Industry code
- NAICS 519, SIC 7375
- Region
- California
- Revenue
- $8.5M a year, as listed
- Full record
- Every detail in the company directory
Biotechnology in United States
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Nora Therapeutics in front of investors. Or tell us what we have wrong.